IMBDX, INC. revenue for the last year amounted to 4.00 B KRW, the most of which — 3.00 B KRW — came from its highest performing source at the moment, Genetic Analysis Services and Medical Research Services, the year earlier bringing 1.90 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought IMBDX, INC. 3.20 B KRW, and the year before that — 2.20 B KRW.